MDB Capital Holdings (MDBH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Report covers the quarter ended March 31, 2026, with 5,438,632 Class A shares outstanding as of May 14, 2026.
Operates two segments: broker dealer & intellectual property services, and technology development.
eXoZymes transitioned to a minority-owned equity method investment after its IPO in November 2024.
Financial highlights
Net loss attributable to members was $6.7 million for Q1 2026, compared to $6.6 million in Q1 2025.
Total revenue (net operating income) was $44,000, down from $828,000 year-over-year.
Fee income from the broker dealer increased to $2.86 million from $2.14 million year-over-year.
Unrealized losses on investment securities (licensed broker dealer) were $3.05 million, up from $1.46 million.
Cash and cash equivalents at March 31, 2026, were $12.2 million, down from $13.2 million at year-end.
Outlook and guidance
Management notes ongoing monitoring of macroeconomic risks, including inflation, supply chain, and geopolitical conflicts.
No specific forward-looking financial guidance provided.
Latest events from MDB Capital Holdings
- AI-driven platform scaling, asset spinouts, and $22.3M cash position drive future growth.MDBH
Q4 20252 Apr 2026 - Public venture model delivers liquid, tax-advantaged access to high-growth companies.MDBH
Investor presentation16 Mar 2026 - IPO launches with LTIR, offering downside protection and incentives for long-term investors.MDBH
Status Update15 Jan 2026 - Invizyne IPO, deep tech pipeline, and investor growth drive expansion despite higher losses.MDBH
Q3 202412 Jan 2026 - eXoZymes IPO and deconsolidation clarify results as platform and investor base expand.MDBH
Q4 202426 Dec 2025 - Shareholders will vote on directors and auditor, with control held by Class B shares and strong governance oversight.MDBH
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and governance policies.MDBH
Proxy Filing2 Dec 2025 - Q2 2025 net loss rose to $8.25M as focus shifts to profitable IPOs and a PatentVest spin-off.MDBH
Q2 202523 Nov 2025 - Scaling launches and major equity deals position for upside as market recovery is expected.MDBH
Q3 202521 Nov 2025